交易 Guardion Health Sciences, Inc. - GHSI CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.8604 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.030779% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | -0.013666% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 0.01 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 6.8879 | 0.2174 | 3.26% | 6.6705 | 6.8879 | 6.6705 |
Jan 31, 2023 | 6.8218 | 0.1358 | 2.03% | 6.6860 | 6.9070 | 6.6860 |
Jan 30, 2023 | 6.7592 | -0.4160 | -5.80% | 7.1752 | 7.1850 | 6.7207 |
Jan 27, 2023 | 7.0871 | 1.0265 | 16.94% | 6.0606 | 7.0969 | 6.0368 |
Jan 26, 2023 | 6.2554 | -0.0521 | -0.83% | 6.3075 | 6.4640 | 6.1478 |
Jan 25, 2023 | 6.4113 | 0.4301 | 7.19% | 5.9812 | 6.4113 | 5.9281 |
Jan 24, 2023 | 6.1516 | 0.0155 | 0.25% | 6.1361 | 6.1719 | 5.9770 |
Jan 23, 2023 | 6.1686 | -0.1878 | -2.95% | 6.3564 | 6.3915 | 6.1680 |
Jan 20, 2023 | 6.4287 | -0.2424 | -3.63% | 6.6711 | 6.6967 | 6.3662 |
Jan 19, 2023 | 6.7152 | -0.4098 | -5.75% | 7.1250 | 7.1289 | 6.6909 |
Jan 18, 2023 | 7.1752 | -0.4787 | -6.25% | 7.6539 | 7.6637 | 7.1509 |
Jan 17, 2023 | 7.5571 | 0.0502 | 0.67% | 7.5069 | 7.6246 | 7.2362 |
Jan 13, 2023 | 7.8073 | 0.1620 | 2.12% | 7.6453 | 7.8268 | 7.3126 |
Jan 12, 2023 | 7.5489 | 0.1040 | 1.40% | 7.4449 | 7.6363 | 6.9274 |
Jan 11, 2023 | 6.9238 | 0.2378 | 3.56% | 6.6860 | 7.4242 | 6.6860 |
Jan 10, 2023 | 7.0771 | 0.8651 | 13.93% | 6.2120 | 7.5778 | 6.2120 |
Jan 9, 2023 | 6.6022 | 0.9372 | 16.54% | 5.6650 | 6.9475 | 5.4542 |
Jan 6, 2023 | 0.1133 | -0.0213 | -15.82% | 0.1346 | 0.1386 | 0.1097 |
Jan 5, 2023 | 0.1352 | -0.0044 | -3.15% | 0.1396 | 0.1398 | 0.1338 |
Jan 4, 2023 | 0.1386 | 0.0001 | 0.07% | 0.1385 | 0.1439 | 0.1371 |
Guardion Health Sciences, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
总收入 | 0.14103 | 0.43735 | 0.94215 | 0.90294 | 1.88984 | 7.23312 |
收入 | 0.14103 | 0.43735 | 0.94215 | 0.90294 | 1.88984 | 7.23312 |
收入成本,共计 | 0.0757 | 0.17547 | 0.39818 | 0.34132 | 1.3307 | 4.12268 |
毛利 | 0.06533 | 0.26188 | 0.54397 | 0.56162 | 0.55914 | 3.11044 |
总营业费用 | 4.08672 | 5.71879 | 7.08587 | 11.3999 | 10.4416 | 31.9799 |
销售/一般/行政费用,总计 | 3.66462 | 5.24827 | 6.19334 | 9.26249 | 8.87082 | 13.476 |
研究与开发 | 0.03654 | 0.22989 | 0.19732 | 0.16131 | 0.12513 | 0.02625 |
Depreciation / Amortization | 0.06013 | 0.06516 | 0.29704 | 0.07124 | 0.06548 | 0.09158 |
异常费用(收入) | 0.24974 | 0 | 1.56352 | 0.04945 | 14.2634 | |
营业收入 | -3.94569 | -5.28144 | -6.14372 | -10.4969 | -8.55174 | -24.7468 |
利息收入(费用),非经营净值 | -1.10456 | -0.02373 | -1.62369 | 0.03458 | -0.01993 | 0.0018 |
其他,净值 | -0.69815 | 0 | -0.41596 | 0 | ||
税前净收入 | -5.7484 | -5.30517 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
税后净收入 | -5.7484 | -5.30517 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
未计算非常项目前的净收益 | -5.7484 | -5.30517 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
净收入 | -5.7484 | -5.30517 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
Total Adjustments to Net Income | -0.79503 | -0.91058 | 0 | |||
普通股股东可获收益 (不含非经常性项目) | -6.54343 | -6.21575 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
普通股股东可获收益 (含非經常性項目) | -6.54343 | -6.21575 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
摊薄净收入 | -6.54343 | -6.21575 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
摊薄后加权平均股 | 3.63353 | 4.64482 | 3.36484 | 6.07814 | 14.2569 | 23.6886 |
扣除特别项目的每股摊薄盈利 | -1.80085 | -1.33821 | -2.3084 | -1.78974 | -0.60123 | -1.04459 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
每股正常摊薄盈利 | -1.73212 | -1.33821 | -2.3084 | -1.53251 | -0.59776 | -0.44247 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
总收入 | 0.2333 | 1.22372 | 3.14861 | 2.62749 | 2.38462 |
收入 | 0.2333 | 1.22372 | 3.14861 | 2.62749 | 2.38462 |
收入成本,共计 | 0.13302 | 0.66522 | 1.76059 | 1.56384 | 1.28816 |
毛利 | 0.10028 | 0.5585 | 1.38802 | 1.06365 | 1.09646 |
总营业费用 | 2.90282 | 5.76427 | 6.16413 | 17.1487 | 5.00467 |
销售/一般/行政费用,总计 | 2.7492 | 2.97862 | 4.07525 | 3.72642 | 3.68556 |
研究与开发 | 0.02061 | 0.01676 | 0.01623 | 0.01076 | 0.00669 |
营业收入 | -2.66952 | -4.54055 | -3.01552 | -14.5212 | -2.62005 |
利息收入(费用),非经营净值 | 0 | 0.00027 | 0.00068 | 0.00086 | 0.00156 |
税前净收入 | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
税后净收入 | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
未计算非常项目前的净收益 | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
净收入 | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
普通股股东可获收益 (不含非经常性项目) | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
普通股股东可获收益 (含非經常性項目) | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
摊薄净收入 | -2.66953 | -4.54029 | -3.01484 | -14.5204 | -2.61849 |
摊薄后加权平均股 | 21.3514 | 24.427 | 24.427 | 24.5153 | 39.1509 |
扣除特别项目的每股摊薄盈利 | -0.12503 | -0.18587 | -0.12342 | -0.5923 | -0.06688 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.12503 | -0.09975 | -0.11065 | -0.10902 | -0.06626 |
异常费用(收入) | 2.10368 | 0.31206 | 11.8477 | 0.02426 | |
Other Operating Expenses, Total | 0 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
流动资产总额 | 0.13756 | 5.0799 | 1.10492 | 11.8677 | 9.09488 | 12.0692 |
现金和短期投资 | 0.06252 | 4.73523 | 0.67095 | 11.1155 | 8.51873 | 9.08955 |
Cash | 0.06252 | 4.73523 | 0.67095 | 11.1155 | 8.51873 | 4.09393 |
应收账款总额,净额 | 0.00167 | 0.07277 | 0.0282 | 0.07834 | 0.01125 | 1.41157 |
Accounts Receivable - Trade, Net | 0.00167 | 0.07277 | 0.0282 | 0.07834 | 0.01125 | 1.41157 |
Total Inventory | 0.044 | 0.15473 | 0.358 | 0.31094 | 0.38497 | 0.36769 |
Prepaid Expenses | 0.02936 | 0.11716 | 0.04777 | 0.36294 | 0.17993 | 1.20038 |
Total Assets | 0.26205 | 7.37022 | 3.6811 | 12.8768 | 9.8609 | 23.4606 |
Property/Plant/Equipment, Total - Net | 0.11402 | 0.0956 | 0.2748 | 0.94735 | 0.70427 | 0.13564 |
Property/Plant/Equipment, Total - Gross | 0.27718 | 0.27196 | ||||
Accumulated Depreciation, Total | -0.16316 | -0.13633 | ||||
Other Long Term Assets, Total | 0.01047 | 0.01047 | 0.28175 | 0.01175 | 0.01175 | 0 |
Total Current Liabilities | 0.60762 | 0.49995 | 0.49534 | 0.41023 | 1.07373 | 1.15905 |
Accounts Payable | 0.35647 | 0.31124 | 0.41393 | 0.12913 | 0.60831 | 0.24135 |
Accrued Expenses | 0.08829 | 0.01204 | 0.08141 | 0.26778 | 0.29048 | 0.9177 |
Notes Payable/Short Term Debt | 0 | 0.03054 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.07138 | 0 | ||||
Other Current Liabilities, Total | 0.09148 | 0.14613 | 0 | 0.01332 | 0.17494 | 0 |
Total Liabilities | 0.60762 | 0.49995 | 0.49534 | 0.84498 | 1.34563 | 1.16285 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | |||||
Total Equity | -0.34557 | 6.87028 | 3.18576 | 12.0318 | 8.51527 | 22.2978 |
Preferred Stock - Non Redeemable, Net | 0.00171 | 0 | 0 | 0 | 0 | |
Common Stock | 0.02505 | 0.04018 | 0.02056 | 0.07498 | 0.01517 | 0.02443 |
Additional Paid-In Capital | 20.2779 | 33.696 | 37.7986 | 57.4685 | 62.5834 | 101.075 |
Retained Earnings (Accumulated Deficit) | -20.6502 | -26.866 | -34.6334 | -45.5117 | -54.0833 | -78.8021 |
Total Liabilities & Shareholders’ Equity | 0.26205 | 7.37022 | 3.6811 | 12.8768 | 9.8609 | 23.4606 |
Total Common Shares Outstanding | 4.17449 | 6.69725 | 3.42739 | 12.4971 | 15.1706 | 24.427 |
Goodwill, Net | 1.56352 | 1.56352 | 0 | |||
Intangibles, Net | 0.62074 | 0.4561 | 0.05 | 0.05 | 11.2558 | |
Other Liabilities, Total | 0.43475 | 0.2719 | 0.00381 | |||
短期投资 | 4.99562 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 43.9956 | 16.5469 | 14.8666 | 12.0692 | 20.568 |
现金和短期投资 | 43.3297 | 12.5027 | 10.5587 | 9.08955 | 16.8296 |
Cash | 43.3297 | 5.50241 | 3.56385 | 4.09393 | 4.83247 |
应收账款总额,净额 | 0.0649 | 1.88478 | 2.26862 | 1.41157 | 2.19839 |
Accounts Receivable - Trade, Net | 0.0649 | 1.88478 | 2.26862 | 1.41157 | 2.19839 |
Total Inventory | 0.28853 | 0.95626 | 0.79263 | 0.36769 | 0.82233 |
Prepaid Expenses | 0.31252 | 1.20317 | 1.24671 | 1.20038 | 0.71763 |
Total Assets | 44.7025 | 41.2848 | 38.6132 | 23.4606 | 31.6205 |
Property/Plant/Equipment, Total - Net | 0.6451 | 0.58497 | 0.29879 | 0.13564 | 0.09423 |
Property/Plant/Equipment, Total - Gross | 1.10614 | 1.06743 | 0.45973 | 0.27196 | 0.22405 |
Accumulated Depreciation, Total | -0.46105 | -0.48245 | -0.16094 | -0.13633 | -0.12982 |
Intangibles, Net | 0.05 | 11.8508 | 11.5533 | 11.2558 | 10.9583 |
Other Long Term Assets, Total | 0.01175 | 0.31408 | 0.00128 | 0 | |
Total Current Liabilities | 0.98269 | 1.80496 | 1.97012 | 1.15905 | 1.82641 |
Accounts Payable | 0.2304 | 0.76834 | 1.18296 | 0.24135 | 1.14637 |
Accrued Expenses | 0.68458 | 1.03662 | 0.78717 | 0.9177 | 0.68004 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.06771 | 0 | 0 | 0 | |
Total Liabilities | 1.21212 | 1.99139 | 1.97012 | 1.16285 | 1.82641 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.22943 | 0.18643 | 0 | 0.00381 | 0 |
Total Equity | 43.4903 | 39.2934 | 36.6431 | 22.2978 | 29.7941 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.02443 | 0.02443 | 0.02443 | 0.02443 | 0.06143 |
Additional Paid-In Capital | 100.193 | 100.536 | 100.9 | 101.075 | 111.153 |
Retained Earnings (Accumulated Deficit) | -56.7269 | -61.2669 | -64.2817 | -78.8021 | -81.4206 |
Total Liabilities & Shareholders’ Equity | 44.7025 | 41.2848 | 38.6132 | 23.4606 | 31.6205 |
Total Common Shares Outstanding | 24.427 | 24.427 | 24.427 | 24.427 | 61.427 |
短期投资 | 7.00027 | 6.99481 | 4.99562 | 11.9971 | |
Goodwill, Net | 11.9881 | 11.8931 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
净收入/起跑线 | -5.7484 | -5.30517 | -7.76741 | -10.8783 | -8.57166 | -24.745 |
经营活动产生的现金 | -1.65357 | -3.4037 | -4.17383 | -6.03 | -8.01393 | -10.6444 |
经营活动产生的现金 | 0.06013 | 0.11882 | 0.29567 | 0.47735 | 0.06548 | 0.78292 |
非现金物品 | 3.91755 | 2.11532 | 3.21643 | 4.8027 | 0.79114 | 13.7546 |
营运资金的变化 | 0.11714 | -0.33267 | 0.08147 | -0.43174 | -0.29889 | -0.43689 |
投资活动产生的现金 | -0.00335 | -0.03239 | -0.31024 | -0.17108 | -0.03473 | -31.0114 |
资本支出 | -0.00335 | -0.03728 | -0.31024 | -0.17108 | -0.04073 | -0.07459 |
融资活动产生的现金 | 1.7056 | 8.10879 | 0.41979 | 16.6456 | 5.45189 | 37.231 |
融资现金流项目 | 0.2156 | 0.05465 | -0.41613 | 0 | ||
股票的发行(报废),净额 | 1.145 | 8.105 | 0.86646 | 16.3962 | 5.45189 | 37.231 |
债务的发行(退还),净额 | 0.345 | -0.05086 | -0.03054 | 0.24945 | ||
现金净变化 | 0.04867 | 4.67271 | -4.06428 | 10.4445 | -2.59677 | -4.42481 |
其他投资现金流量项目,总计 | 0.0049 | 0 | 0.006 | -30.9368 | ||
Cash Taxes Paid | 0 | 0 | 0 | 0 | ||
已付现金利息 | 0 | 0 | 0.00727 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -2.66953 | -7.20981 | -10.2247 | -24.745 | -2.61849 |
Cash From Operating Activities | -2.42007 | -7.28535 | -9.07817 | -10.6444 | -2.22647 |
Cash From Operating Activities | 0.0197 | 0.14028 | 0.45778 | 0.78292 | 0.31705 |
Non-Cash Items | 0.42709 | 0.81004 | 1.52679 | 13.7546 | 0.17013 |
Cash Taxes Paid | 0.00936 | 0.02084 | 0.02084 | 0 | 0 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 |
Changes in Working Capital | -0.19733 | -1.02585 | -0.8381 | -0.43689 | -0.09516 |
Cash From Investing Activities | 0 | -32.962 | -33.1077 | -31.0114 | -7.00392 |
Capital Expenditures | 0 | -0.00114 | -0.07681 | -0.07459 | -0.0024 |
Cash From Financing Activities | 37.231 | 37.231 | 37.231 | 37.231 | 9.96894 |
Issuance (Retirement) of Stock, Net | 37.231 | 37.231 | 37.231 | 37.231 | 9.96894 |
Net Change in Cash | 34.8109 | -3.01632 | -4.95488 | -4.42481 | 0.73854 |
Other Investing Cash Flow Items, Total | -32.9608 | -33.0309 | -30.9368 | -7.00152 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Radoff (Bradley Louis) | Individual Investor | 20.2757 | 249800 | 155800 | 2023-01-10 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.7986 | 34479 | 2984 | 2022-09-30 | HIGH |
Radoff Family Foundation | Corporation | 2.0373 | 25100 | 12700 | 2023-01-09 | HIGH |
Millennium Management LLC | Hedge Fund | 1.3261 | 16338 | 9022 | 2022-09-30 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.814 | 10029 | 0 | 2022-09-30 | LOW |
Scholtes (Bret D) | Individual Investor | 0.4789 | 5900 | -743 | 2022-12-02 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.4751 | 5853 | 5454 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.468 | 5766 | -15755 | 2022-09-30 | LOW |
Barclays Capital Inc. | Research Firm | 0.4058 | 5000 | 0 | 2022-09-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.2757 | 3397 | 0 | 2022-09-30 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.2477 | 3052 | 1494 | 2022-09-30 | LOW |
Ergoteles Capital | Hedge Fund | 0.2235 | 2754 | 2754 | 2022-09-30 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2191 | 2699 | 0 | 2022-09-30 | LOW |
Weingarten (Robert Neal) | Individual Investor | 0.1928 | 2375 | 0 | 2022-12-02 | LOW |
Goldstone (Mark) | Individual Investor | 0.1421 | 1751 | 0 | 2022-12-02 | LOW |
Virtu Americas LLC | Research Firm | 0.1287 | 1586 | -774 | 2022-09-30 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0936 | 1153 | 657 | 2022-09-30 | LOW |
Balyasny Asset Management LP | Hedge Fund | 0.0728 | 897 | 897 | 2022-09-30 | HIGH |
Tower Research Capital LLC | Hedge Fund | 0.0626 | 771 | -693 | 2022-09-30 | HIGH |
Gagliano (Donald A) | Individual Investor | 0.045 | 555 | 0 | 2022-12-02 | LOW |
为什么选择 Capital.com?让我们的数字来说话。
Capital.com Group交易計算器
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
貿易佣金
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
杠杆
20:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Guardion Health Sciences, Inc. Company profile
关于 Guardion Health Sciences Inc
Guardion Health Sciences, Inc.是一家临床营养和诊断公司。 公司提供以科学为基础、有临床支持的产品和设备组合,旨在支持医疗保健专业人员和供应商及其病人和消费者。 公司通过Activ Nutritional, LLC (Activ)拥有Viactiv系列补充剂嚼片,用于骨骼健康、免疫健康和其他应用。 Viactiv补充剂系列包含多种口味的营养补充剂产品,但牛奶巧克力和焦糖口味的钙咀嚼片构成了主要的产品类别。 该公司还销售Lumega-Z,其医用食品的配方旨在补充和恢复黄斑保护性色素,同时为眼睛提供关键和必要的营养物质。 公司的GlaucoCetin是一种医用食品,它提供的配方旨在支持青光眼患者视神经细胞的适当线粒体功能。
Industry: | Pharmaceuticals (NEC) |
2925 Richmond Avenue
Suite 1200
HOUSTON
TEXAS 77098
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。